AlphaFold predicted structure
PYCR1 · P32322

Mean pLDDT
89.8/ 100
Confident
319 residues
Confidence breakdown
- Very high(≥ 90)84%
- Confident(70–90)2%
- Low(50–70)4%
- Very low(< 50)10%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
pyrroline-5-carboxylate reductase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalEhlers Danlos syndrome with a likely monogenic cause
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
+4 more panels — install the extension to see the full list inline on any page.
autosomal recessive cutis laxa type 2B
PYCR1-related de Barsy syndrome
cutis laxa
hereditary disease
geroderma osteodysplastica
de Barsy syndrome
Intellectual disability
Abnormality of connective tissue
neurodegenerative disease
lung cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Pyrroline-5-carboxylate reductase 1, mitochondrial
Oxidoreductase that catalyzes the last step in proline biosynthesis, which corresponds to the reduction of pyrroline-5-carboxylate to L-proline using NAD(P)H (PubMed:16730026, PubMed:19648921, PubMed:23024808, PubMed:28258219). At physiologic concentrations, has higher specific activity in the presence of NADH (PubMed:16730026, PubMed:23024808). Involved in the cellular response to oxidative stress (PubMed:16730026, PubMed:19648921)
PYCR1 · P32322

Mean pLDDT
89.8/ 100
Confident
319 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0